G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients

Some studies have pointed to a role of TNF-alpha in pathogenesis of non alcoholic fatty liver disease (NAFLD). The aim of our study was to investigate the influence of G308A polymorphism TNF alpha gene on the histological changes, insulin resistance and TNF-alpha levels in overweight patients. A pop...

Full description

Saved in:
Bibliographic Details
Published in:Annals of hepatology 2010-10, Vol.9 (4), p.439-444
Main Authors: Aller, Rocio, de Luis, Daniel Antonio, Izaola, Olatz, González Sagrado, Manuel, Conde, Rosa, Alvarez Gago, Tomas, Pacheco, David, González, Jose Manuel, Velasco, María Concepcion
Format: Article
Language:English
Subjects:
Adult
Body Mass Index
Cross-Sectional Studies
Fatty Liver - genetics
Fatty Liver - pathology
Female
Genetic Predisposition to Disease - genetics
Genotype
Humans
Insulin resistance
Insulin Resistance - genetics
Liver biopsy
Male
Middle Aged
Multivariate Analysis
Non-alcoholic Fatty Liver Disease
Overweight - genetics
Polymorphism, Single Nucleotide - genetics
Severity of Illness Index
TNF-alpha
Tumor Necrosis Factor-alpha - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Some studies have pointed to a role of TNF-alpha in pathogenesis of non alcoholic fatty liver disease (NAFLD). The aim of our study was to investigate the influence of G308A polymorphism TNF alpha gene on the histological changes, insulin resistance and TNF-alpha levels in overweight patients. A population of 66 patients with NAFLD was recruited in a cross sectional study. A biochemical analysis of serum was measured. Genotype of TNF alpha gene G308A was studied. Fifteen patients (22.7%) had the genotype G308A (mutant type group) and 51 patients (77.3%) G308G (wild type group). Patients with mutant type group presented more moderate-severe portal inflammation (86.7%) in liver biopsy compared to patient with wild genotype (19.7%). Mutant type group had more moderate-severe fibrosis (73.3%) than wild type group (51.3%). The multivariate analysis adjusted by age, sex, BMI and genotype with the dependent variable (fibrosis) showed that HOMA remained in the model, with an increase of the probability to develop fibrosis of 1.78 (CI95%:1.06-3.2) and develop moderate-severe inflammation of 1.45 (CI95%:1.02-2.1) with each increase of one unit on HOMA levels. In conclusion, Patients with mutant genotype have more frequently moderate-severe portal inflammation and fibrosis than wild type genotype.
ISSN:1665-2681
DOI:10.1016/s1665-2681(19)31620-5